Search research articles
Contact Us
Filters
Showing results (1-10 of 59) with videos related to
Page
of 6
Sort By:
Oncotarget
|
March 9, 2022
Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations
Antonio Marchetti, Fiamma Buttitta, Emanuela D'Angelo
Oncotarget
|
December 21, 2019
An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatments
Antonio Marchetti, Alessia Di Lorito, Lara Felicioni, et al.
Human Pathology
|
September 6, 2023
Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor
Emanuela D'Angelo, Iñigo Espinosa, Lara Felicioni, et al.
Frontiers in Surgery
|
May 1, 2024
Case Report: The molecular fingerprint and the clinical implication of an exceptional response to neoadjuvant therapy in a metastatic cardia adenocarcinoma
Laura Lorenzon, Andrea Campisi, Alessandra Di Paolo, et al.
Pathologica
|
July 1, 2022
NTRK gene fusions in solid tumors: agnostic relevance, prevalence and diagnostic strategies
Antonio Marchetti, Benedetta Ferro, Maria Paola Pasciuto, et al.
International Medical Case Reports Journal
|
June 6, 2017
Extraordinary and prolonged erlotinib-induced clinical response in a patient with EGFR wild-type squamous lung cancer in third-line therapy: a case report
Elisabetta Gambale, Consiglia Carella, Paolo Amerio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 16, 2013
microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer
Riccardo Cazzoli, Fiamma Buttitta, Marta Di Nicola, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
November 4, 2015
Reduction of atherothrombotic burden before stent deployment in non-ST elevation acute coronary syndromes: Reduction of myocardial necrosis achieved with nose-dive manual thrombus aspiration (REMNANT) trial. A volumetric intravascular ultrasound study
Marco Zimarino, Francesca Angeramo, Abhiram Prasad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2004
Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome
Antonio Marchetti, Fabio Barassi, Carla Martella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry
Caterina Pellegrini, Monica Falleni, Antonio Marchetti, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 59) with videos related to
Sort By:
Page
of 6
Oncotarget
|
March 9, 2022
Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations
Antonio Marchetti, Fiamma Buttitta, Emanuela D'Angelo
Oncotarget
|
December 21, 2019
An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatments
Antonio Marchetti, Alessia Di Lorito, Lara Felicioni, et al.
Human Pathology
|
September 6, 2023
Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor
Emanuela D'Angelo, Iñigo Espinosa, Lara Felicioni, et al.
Frontiers in Surgery
|
May 1, 2024
Case Report: The molecular fingerprint and the clinical implication of an exceptional response to neoadjuvant therapy in a metastatic cardia adenocarcinoma
Laura Lorenzon, Andrea Campisi, Alessandra Di Paolo, et al.
Pathologica
|
July 1, 2022
NTRK gene fusions in solid tumors: agnostic relevance, prevalence and diagnostic strategies
Antonio Marchetti, Benedetta Ferro, Maria Paola Pasciuto, et al.
International Medical Case Reports Journal
|
June 6, 2017
Extraordinary and prolonged erlotinib-induced clinical response in a patient with EGFR wild-type squamous lung cancer in third-line therapy: a case report
Elisabetta Gambale, Consiglia Carella, Paolo Amerio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 16, 2013
microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer
Riccardo Cazzoli, Fiamma Buttitta, Marta Di Nicola, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
November 4, 2015
Reduction of atherothrombotic burden before stent deployment in non-ST elevation acute coronary syndromes: Reduction of myocardial necrosis achieved with nose-dive manual thrombus aspiration (REMNANT) trial. A volumetric intravascular ultrasound study
Marco Zimarino, Francesca Angeramo, Abhiram Prasad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2004
Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome
Antonio Marchetti, Fabio Barassi, Carla Martella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry
Caterina Pellegrini, Monica Falleni, Antonio Marchetti, et al.
Page
of 6